NEURO-PHARMACOLOGICAL STUDIES ON THE NEUROLEPTIC POTENTIAL OF DOMPERIDONE (R33812)

被引：77
作者：
COSTALL, B
FORTUNE, DH
NAYLOR, RJ
机构：
[1] Postgraduate School of Studies in Pharmacology, University of Bradford, Bradford
来源：
JOURNAL OF PHARMACY AND PHARMACOLOGY | 1979年 / 31卷 / 05期
关键词：
D O I：
10.1111/j.2042-7158.1979.tb13518.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：344 / 347
页数：4
相关论文
共 13 条
[1]  
BAEYENS R, 1978, ARZNEIMITTELFORSCH, V28-1, P682
[2]   CLIMBING BEHAVIOR INDUCED BY APOMORPHINE IN MICE - POTENTIAL MODEL FOR DETECTION OF NEUROLEPTIC ACTIVITY [J].
COSTALL, B ;
NAYLOR, RJ ;
NOHRIA, V .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 50 (01) :39-50
[3]  
COSTALL B, 1973, ARZNEIMITTEL-FORSCH, V23, P674
[4]   COMPARISON OF ABILITIES OF TYPICAL NEUROLEPTIC AGENTS AND OF THIORIDAZINE, CLOZAPINE, SULPIRIDE AND METOCLOPRAMIDE TO ANTAGONIZE HYPERACTIVITY INDUCED BY DOPAMINE APPLIED INTRACEREBRALLY TO AREAS OF EXTRAPYRAMIDAL AND MESOLIMBIC SYSTEMS [J].
COSTALL, B ;
NAYLOR, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 40 (01) :9-19
[5]   DETECTION OF NEUROLEPTIC PROPERTIES OF CLOZAPINE, SULPIRIDE AND THIORIDAZINE [J].
COSTALL, B ;
NAYLOR, RJ .
PSYCHOPHARMACOLOGIA, 1975, 43 (01) :69-74
[6]   MESOLIMBIC INVOLVEMENT WITH BEHAVIORAL-EFFECTS INDICATING ANTIPSYCHOTIC ACTIVITY [J].
COSTALL, B ;
NAYLOR, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1974, 27 (01) :46-58
[7]   IMPORTANCE OF ASCENDING DOPAMINERGIC SYSTEMS TO EXTRAPYRAMIDAL AND MESOLIMBIC BRAIN AREAS FOR CATALEPTIC ACTION OF NEUROLEPTIC AND CHOLINERGIC AGENTS [J].
COSTALL, B ;
NAYLOR, RJ .
NEUROPHARMACOLOGY, 1974, 13 (05) :353-364
[8]   SUBSTITUTED BENZAMIDES AS CEREBRAL DOPAMINE ANTAGONISTS IN RODENTS [J].
ELLIOTT, PNC ;
JENNER, P ;
HUIZING, G ;
MARSDEN, CD ;
MILLER, R .
NEUROPHARMACOLOGY, 1977, 16 (05) :333-342
[9]  
JANSSEN PAJ, 1970, MODERN PROBLEMS PHAR, V5
[10]   SPIPERONE - LIGAND OF CHOICE FOR NEUROLEPTIC RECEPTORS .1. KINETICS AND CHARACTERISTICS OF INVITRO BINDING [J].
LEYSEN, JE ;
GOMMEREN, W ;
LADURON, PM .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (03) :307-316
12